OncoCyte (OCX) Misses Q4 EPS by 193c
Tweet
Share
E-mailGet Alerts OCX Hot Sheet
Join SI Premium – FREE
OncoCyte (NASDAQ: OCX) reported Q4 EPS of ($1.93). Revenue for the quarter came in at $1.49 million.
For earnings history and earnings-related data on OncoCyte (OCX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Regency Centers (REG) Tops Q2 EPS by 2c
- Heritage Global to wind down specialty lending unit, expects material charge
- Contineum Therapeutics, Inc. (CTNM) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
